Excellerate Bioscience was established in 2016, with a mission to provide agility and the highest quality molecular and cellular pharmacology services for our clients in drug discovery.

Our founding team brings over 50 years of combined industrial pharmacology expertise in leadership roles.  We combine this with an international reputation in analytical pharmacology and training, with our directors making substantive contributions to new methodologies and techniques in compound discovery and profiling.

Since Excellerate’s inception, we have grown rapidly as a CRO working with our academic, large pharma and single asset partners.  We have built a team of dedicated, collaborative scientists focused on excellence and delivery, housed in state-of-the-art facilities at Nottingham’s prestigious NG2 Business Park.  Our successful programs have supported major partnerships with industry and the development of highly trained pharmacology teams for our clients.  We also continue to invest in capabilities, R&D methodology and assay platform development, partly supported by major EU collaborations and grant funding.

Our Capabilities